Abstract:Background Rheumatoid arthritis (RA) is a prevalent systemic autoimmune disease characterized by the production of autoantibodies1. The tonsil has been demonstrated to be a site of citrullination, and tonsillectomy has been reported to be a potential treatment of RA, suggesting the possibility that the tonsil could be a site of autoimmunity generation in RA2,3. The dysbiosis of gut microbiome and the associated host immune response has been implicated in the initiation and progression of RA4–6. However, there is no in-depth studies on the role of tonsil microbiota in RA. Thus, studies of the characteristics of tonsil microbiome in RA patients, the underlying mechanisms, as well as specific markers for the diagnosis and therapeutic evaluation for RA, are critical for the early diagnosis and prevention of RA. Objectives Therefore, we aimed to define the association of RA with tonsil microbiome as well as a microbial and metabolite profile that could predict disease status. Methods 16S rRNA gene sequencing was utilized on 220 tonsil swab samples (121 RA patients and 99 healthy controls) as well as 78 fecal samples (68 RA and 10 controls). Analysis of microbial taxa and metabolic pathway were performed to characterise and compare the tonsil microbiome of RA patients and healthy subjects Results Results showed that the tonsil harbored a unique microbiome relative to that present in the fecal samples. Patients with RA exhibited different tonsil microbiome from controls. A taxon-level analysis suggested that the relative abundance of 26 microbial clades were significantly altered, with 7 taxa increased and 19 taxa decreased in RA samples. Noticeably, we observed an expansion of rare microbial lineages as well as an alteration in microbial cladogenesis within RA patients. RA tonsil microbiota was associated with smoke, anti-peripheral factor, rheumatoid factors, disease duration and activity. Furthermore, we identified that 86 genes associated with bacterial metabolic pathway were enriched in RA tonsil microbiome. Conclusions Our results demonstrated that the RA tonsil microbiome differs from that of healthy controls, which correlates with systemic autoimmune changes and may potentially drives initiation of RA. References McInnes IB, and Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011, 365(23): 2205–2219. Kawano M, Okada K, Muramoto H, et al. Simultaneous, clonally identical T cellexpansion in tonsil and synovium in a patient with rheumatoid arthritis and chronic tonsillitis. Arthritis Rheum. 2003, 48(9): 2483–2488. Makrygiannakis D, af Klint E, Lundberg IE, et al. Citrullination is an inflammation-dependent process. Ann Rheum Dis. 2006, 65(9): 1219–1222. Scher JU and Abramson SB. The microbiome and rheumatoid arthritis. Nat Rev Rheumatol, 2011, 7(10): 569–578. Scher JU, Sczesnak A, Longman RS, et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife, 2013, 2:e01202. Zhang X, Zhang D, Jia H, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med, 2015, 21(8): 895–905. Disclosure of Interest None declared

Oral mucosal breaks trigger anti-citrullinated bacterial and human protein antibody responses in rheumatoid arthritis

Antibodies to a Citrullinated Porphyromonas Gingivalis Epitope Are Increased in Early Rheumatoid Arthritis, and Can Be Produced by Gingival Tissue B Cells: Implications for a Bacterial Origin in RA Etiology

Infectious Triggers in Periodontitis and the Gut in Rheumatoid Arthritis (RA): A Complex Story About Association and Causality

Oral Microbial Dysbiosis Linked to Worsened Periodontal Condition in Rheumatoid Arthritis Patients

Interplay of Microbiota and Citrullination in the Immunopathogenesis of Rheumatoid Arthritis

Oral Microbiota Perturbations Are Linked to High Risk for Rheumatoid Arthritis

Distinct mucosal endotypes as initiators and drivers of rheumatoid arthritis

Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis

The Infectious Basis of ACPA-Positive Rheumatoid Arthritis

Is localized autoimmunity the trigger for rheumatoid arthritis? Unravelling new targets for prevention

Bone Loss and Aggravated Autoimmune Arthritis in HLA-DRβ1-bearing Humanized Mice Following Oral Challenge with Porphyromonas Gingivalis

Antibodies to Porphyromonas gingivalis Indicate Interaction Between Oral Infection, Smoking, and Risk Genes in Rheumatoid Arthritis Etiology

Impaired Periodontitis-Induced Cytokine Production by Peripheral Blood Monocytes and Myeloid Dendritic Cells in Patients with Rheumatoid Arthritis: A Case-Control Study

Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss

Oral and Intestinal Bacterial Substances Associated with Disease Activities in Patients with Rheumatoid Arthritis: A Cross-Sectional Clinical Study

Another Look at the Contribution of Oral Microbiota to the Pathogenesis of Rheumatoid Arthritis: A Narrative Review

Associations between serum antibodies to periodontal pathogens and preclinical phases of rheumatoid arthritis

FRI0084 the Tonsil Microbiome is Involved in Rheumatoid Arthritis

Connecting the dots: NETosis and the periodontitis‐rheumatoid arthritis nexus

Antibodies to Citrullinated Proteins: Molecular Interactions and Arthritogenicity

Presence and Immunoreactivity of Aggregatibacter actinomycetemcomitans in Rheumatoid Arthritis